SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company
NKTR 57.74-2.7%Nov 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (249)7/23/2007 2:09:03 PM
From: Ian@SI   of 507
 
According to FBR, NKTR has already approached its 12 month target
for the bottom...

Friedman, Billings & Ramsey issued the following share price
target changes on Thursday:

 
Company Name             Symbol   New Trg   Old Trg   Current   Time Span 
 
 
DECREASE: 
 
Nektar Therapeutics      NKTR      $8.00    $14.00     $8.77    12 Months
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News